Phase 2a Study of ZW25 in Combination With Palbociclib Plus Fulvestrant
Study sponsor: Jazz Pharmaceuticals
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-04-28Actual
Enrollment · participants51Actual
Source updated2026-09-24Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.